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Abstract
Two patients with seropositive inflammatory arthropathies who
experienced cihical improvement on the Waianae diet are pre
sented.
The scientific literature validates the usefulness of fasting in the
control ofjoint inflammation. Elimination diets are variably success
ful. Fasting followed by a vegetarian diet can produce a sustained
positive response measured clinically and by laboratory variables of
inflammation, the efficacy of such an approach appears to hinge on
the alteration of fecal flora. Swaying the balance of dietary fats in
favor of the omega 3 and omega 6 fatty acids has an antiinflamma
tory effect, but does not appear to correct the basic immunologic
processes involved in the development of the arthropathies.
Practical guidelines for the application of this information are
offered.
Introductiom The Hawaii Diet Program
The Hawaii Diet is a multi-cultural version of the Waianae Diet
which is based on traditional Hawaiian foods. The Waianae diet
program was developed at the Waianae Coast Comprehensive
Health Center in response to the high rates of obesity and chronic
disease in the native Hawaiian population. The selection of food
consists of items eaten in Hawaii before the onset of Western
influence, including such items as taro (a native potato), poi, sweet
potatoes, yams, breadfruit, rootcrop greens, fruit, seaweed, fish and
chicken. All items are served raw or steamed. The diet contains less
than 10% fat, 12 to 15% protein and 75 to 78% carbohydrate. The
Hawaii diet is based on the same macronutrient composition but
with multi-cultural foods replacing many of the traditional Hawai
ian meals. The Hawaii Diet includes as its staples in addition to poi
and taro, whole starches such as brown rice, pasta, vegetables, fruit,
legumes and a small amount of seafood or poultry.
Both diets have been shown to be effective in the control of high
blood pressure, diabetes and hypercholesterolemia) It has not
heretofore been reported to positively influence the activity of the
inflammatory arthritides.
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Case Reports
Case 1. LS, a 38 year old Japanese female presented with fevers,
20 pound weight loss, joint pain and polyarticular synovitis in the
metacarpophalangeal joints and ankles. Antinuclear antibody titer
was 1:80 with a speckled pattern, sedimentation rate 53 mmlhr;
antibodies to ribonucleoprotein and SSA were present. A presump
tive diagnosis of systemic lupus erythematosus (SLE) was made,
and the patient was started on low-dose oral prednisone (10 mgI
day)supplemented with indomethacin for the control of fever.
Hydroxychloroquine 200 mg/day was eventually added as a steroid
sparing agent.
Two years into the disease course, the patient went on the Hawaii
Diet. The sedimentation rate dropped from the 70 to 90 mmlhr range
to 39 mmlhr. The platelet count, which had been elevated, normal
ized. The patient lost 10 pounds over 3 months. She reported
increased energy, and was able to discontinue indomethacin without
recurrence of the fevers. Synovitis disappeared.
The diet was discontinued after three months. Within a month,
fatigue, rashes, fevers and joint pain had recurred.
Case 2. HS, a 44 year old female of mixed Hawaiian-European
ancestry presented with synovitis in the metacarpophalangeal and
proximal interphalangeal joints. She had an antinuclear antibody
titer of 1:256, and antibody to DNA of217 lU/mI (normal < 100 JU/
ml). A presumptive diagnosis of systemic lupus erythematosus was
made, and the patient was started on prednisone 10 mg/day,
hydroxychloroquine 200mg BID and ketoprofen 200 mg/day. The
response to oral hydroxychioroquine was less than optimal; this
agent was discontinued. Steroid side effects (hyperglycemia, weight
gain, fluid retention and Cushingoid facies) prompted the addition
of oral methotrexate 10 and then 12.5 mg/week. Prednisone was
tapered to 5 mg every other day; doses less than this resulted in
disabling synovitis in the small joints of the hands.
The patient went on the Waianae diet program two years into the
disease course. Within two months, the patient had discontinued the
prednisone. On her own, she also went off the methotrexate a month
later. She remained free of pain and synovitis for another month
after she went off the diet, at which point both the prednisone and
methotrexate had to be restarted.
Neither of these two patients meet strict classification criteria for
SLE, but both clearly had an inflammatory arthropathy accompa
nied by significant serologic markers of autoimmune activity.
-
HAWAII MEDICAL JOURNAL. VOL 58. MAY 1999
126
The Dietary Treatment of Arthritis
Interest in the impact of nutrition on disease causation, activity
and cure is universal among patients with arthritis. The great
majority will attempt some form of dietary manipulation, in large
part unsupervised by and even unknown to their physician.2
Clearly, in gout and saturnine gout, dietary forces have a well-
defined role, the first being a disorder of purine metabolism and
elimination, and the second a lead intoxication state. Obesity is a
risk factor for osteoarthritis, especially in the weight-bearing joints.
Reiter’s syndrome is a reactive arthropathy triggered in some cases
by food pathogens. Beyond these well-defined circumstances,
however, the role of food in the arthropathies is controversial.
Arthritis as a Food Allergy
The literature is replete with case reports of arthritis and synovitis
being temporally associated with the ingestion of certain foods—
dairy products gluten5 and azo dyes6. The behavior of the
arthropathy in these situations satisfies classical medical criteria for
causation—ic. exacerbation with challenge, remission with
dechallenge, and reactivation with rechallenge. By and large,
however, these cases are seronegative and nonerosive. More impor
tantly, they are sporadic and fairly rare.
Elemental hypoallergenic diets have been studied in patients with
rheumatoid arthritis (RA).769 As a group, patients on these diets tend
to do better subjectively, but objective improvements in the labora
tory measures of inflammation do not improve significantly. Cer
tai n individuals respond better than others, but the magnitude of the
response and the number of patients affected favorably are too small
to produce statistical significance. The responders tend to be heavier
at outset, and tend to have greater disease activity than the non-
responders. Van de Laar et al have obtained synovial membrane and
small intestinal biopsies on some of these responders. Mast cells and
IgE bearing cells are decreased at these sites during dietary manipu
lation.7 The authors postulate that these histologic changes suggest
an allergological mechanism underlying the observed arthritis re
sponse.
Kavanaghi et al9 have attempted to sustain improvement by
reinstituting feeding selectively. After an elemental diet, patients
were refed with one food group at a time. Those food groups
followed by a disease flare were eliminated from each individual’s
maintenance regimen. Even such an individualized approach,
however, failed to sustain improvement at 24 weeks.
The Effects of Fasting
Fasting—that is, the voluntary abstention from food for a limited
period of time—has been validated as an effective short-term
suppressor of inflammation in the Subjective
improvement in pain and stiffness starts within three to five days of
the initiation of the fast, and is sustained for its duration. Joint
inflammation indices as well as acute phase reactants (sedimenta
tion rate, orosomucoid, haptoglobins) decrease. Return to pretreat
ment disease activity occurs on the day after the fast is discontinued.
In the hands of most investigators, no maintenance diet can sustain
the benefits of the fast. (An exception to this observation has been
reported, and is reviewed below.)
While almost universal relapse at the termination of the fast makes
fasting an untenable treatment for RA, understanding the mecha
nisms underlying the clinical response is instructive.
Lymphocytes are affected by fasting. Antigen-specific B cell
responses improve.’3 Suppressor cell activity, usually depressed in
RA patients, normalizes with fasting.’4
Neutrophilic functions are also influenced by food deprivation.
Release of the pro-inflammatory chemical leukotriene B4 from
neutrophils goes down, as does the ability to generate cytotoxins in
vitro.” Levels of linoleic and alpha linolenic acids are unchanged;
their metabolites, arachidonic and eicosapentaenoic acid increase.
Such a profile can be produced by impaired activity of phospholi
pase and 5-lipoxygenase, enzymes involved in the metabolism of
arachidonic acid to leukotriene B4. From these data, Hafstrom et al
have postulated stimulus-response decoupling of neutrophil me
tabolism reduced ability to generate cytotoxins, reduced leukotirene
formation) as mechanisms of the antiinflammatory effect of food
deprivation.
Fasting also alters intestinal permeability.’5 Polyethylene glycol
molecules penetrate intestinal mucosa less well during fasting; this
reverses with refeeding of a lactovegetarian diet. If indeed inflam
matory arthritis is an allergic or hyperimmune reaction to foreign
antigens, the decreased penetration of immunostimulants may ex
plain the temporary relief experienced by patients on a fast.
The Oslo Cohort
In the late l980s, investigators in Oslo entered a group of 53
patients with RA in a single-blind controlled trial of diet therapy.
Twenty-seven patients were randomized in a four-week stay at a
health farm. The control group stayed for four weeks at a convales
cent home, but ate an ordinary diet throughout the study period.
Treatment started with a 7 to 10 day subtotal fast. After the fast,
one new food item was introduced every second day.. If this was
followed by an exacerbation in symptoms, the offending food was
withdrawn for one week. If a similar exacerbation occurred with
later rechallenge, then that food item was permanently removed
from the maintenance diet. During the first 14 months, patients were
kept on a strict gluten-free vegan diet (ie no meat, fish, eggs, dairy
products or food containing gluten). After this period, dairy and
gluten were reintroduced. Foods producing a flare in disease
activity were recorded in a personal journal. Clinical and laboratory
assessments were performed at 1,4,7, 10 and 13 months. One year
after conclusion of the study (ie 25 months after the intiation of the
diet), patients were contacted for follow-up examinations.
The results of this study have been published in a series of related
articles covering the clinical, biological, psychosociological and
immunologic sequelae of the intervention. l6. 17. Ill, 19, 20.21.22
After four weeks at the health farm, the diet group showed
significant improvements in the number of tender, swollen joints,
pain, morning stiffness, grip strength, sedimentation rate, C reactive
protein, and Health Assessment Questionnaire score (HAQ; a stan
dardized instrument measuring the ease with which one performs
the activities of daily living). Rest at a health farm did positively
influence disease activity; the control group also demonstrated
improved pain scores. Subjective improvement was accompanied
by statistically significant drops in platelet counts, total IgG, 1gM
rheumatoid factor, C3 activation products, and complement compo
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nents C3 and C4, all of which are consistent with an amelioration of
immunologic hyperactivity.
A little less than half of the experimental group (10 of the 24
evaluable subjects) could be classified as good responders, defined
as having a 2-grade improvement on a subjective global assessment
scale plus a 20% or better decrease in joint count, pain score, HAQ,
and sedimentation rate. These good responders maintained their
improvement at the one-year and two-year evaluation points.
Was there anything unique about these responders—ie are there
characteristics that can identify which patients are likely to benefit
from dietary intervention prior to the fact?
The investigators did determine that:
a. diet responders tended to have had their disease for a shorter
time (mean of 6 years versus 14 years for the nonresponders);
this is consistent with the response to pharmacologic interven
tions, implying a more malleable situation in the early inflam
matory phases of the disease, before chronic damage is in
place,
b. diet responders were more likely to be seronegative (30%
versus 58% for the nonresponders); this is reminiscent of the
data for RA and food allergies, vide supra,
c. diet responders had a significantly lower belief in the effect of
ordinary medical treatment compared with the nonresponders.
The investigators tried to identify laboratory variables that corre
lated with clinical response. They found that neither immunoglobu
un levels nor phospholipid profiles covaried with clinical disease
activity. While RA patients were found to have elevated levels of
antibodies to food allergens (consistent with generalized B cell
hyperactivity), the activity of these immunoglobulins did not corre
late with the disease course. Plasma arachidonic acid levels dropped
initially and returned to baseline with the lactovegetarian diet;
eicosapentaenoic acid levels stayed low throughout the diet. Con
trary to findings from the omega fatty acid literature (vide infra),
plasma phospholipid profiles did not covary with disease activity.
What did appear to be consistently predictive of clinical improve
ment was a change in fecal flora. Gas-liquid chromatography (GLC)
of bacterial cellular fatty acids obtained from stool samples indi
cated that the microbial profile changes significantly in patients
responding to diet therapy.2223 Nonresponders do not exhibit this
variability. Unfortunately, GLC is a sensitive measure of quantita
tive changes in cell wall profiles, but is unable to determine specifi
cally which bacterial species are decreasing or increasing.
Other Diet Programs
A calorie-optimized diet enchanced with fish meals and antioxi
dants has been tested in a single-blind 6 month study in Norway.24
Compliance was monitored through a diet diary. While the study is
confounded by a 26% drop-out rate, those able to follow the diet
demonstrated less morning stiffness, fewer swollen joints, less pain,
and reduced medication cost. Objective laboratory data, however,
did not change.
The Dong diet has also been put forward as a therapeutic diet for
arthritis.2526 This diet was designed by a southern California derma
tologist, Dr. Cohn Dong. He came down with RA and cured himself
by returning to the traditional Chinese diet ofhis childhood. The diet
consists of fish, little meat and occasional fowl, no fruit, herbs or
spices, no dairy products, no alcohol, and no additives or preserva
tives. The diet was tested by the group of Dr. Richard Panush at the
University of Florida in a 10-week randomized double-blind study
involving26patients.27 There were no statistically significant differ
ences between the two groups at any point in the study. Interest
ingly, however, two individuals in the experimental group achieved
noteworthy disease control, and elected to remain on the diet after
termination of the study. Both had strong personal and family
histories of atopy—other than this one observation, nothing else
distinguished these remarkable responders from the rest of the
subjects.
The Role of Dietary Fats
Fatty acids seem to have some effect on the inflammatory process
possibly as a result of their role as precurcors to prostaglandins and
leukotrienes. N-3 (the designation refers to the location of the first
double bond in the carbon chain, counting from the amino terminus)
fatty acids are antiinflammatory. The 20-carbon n-6 and n-3 fatty
acids archidonic acid (AA) and eicosapentaenoic acid (EPA) are
biosynthetic precursors for n-6 and n-3 eicosanoids of the leukotriene
(LT)and prostaglandin (PG) families. The n-6 eicosanoids LTB4
and PGE2 are pro-inflammatory, causing neutrophil chemotaxis
and activation as well as increased vascular permeability.25 The n
3 homologs are either less active (LTB5) or poorly synthesized from
Table 1 —Sources, relationships and inflammatory effects of some metabolically important unsaturated fatty acids (adapted from 32).
Abbreviations used: PG . prostaglandin, LT- leukotriene, TNF - tumor necrosis factor, IL- interteukhi.
n-6 n-3
18 Carbon Fatty Acids Linoleic Acid C 18:2 Linolenic Acid Cl8:3
Sources Soybean, sunflower and corn oil Flaxseed, canola oil
20 Carbon Fatty Acids Arachidonic Acid C20:4 Eicosapentaerioic Acid C20:5
Sources From meat and ingested From ingested hinolenic acid, and
linoleic acid from fish and fish oil
Metabolized to Proinflammatory n-6 PGs and Competitive inhibitors of n-6
LTs PGs and LT synthesis
Effect on cytokines Unknown Suppression of TNFa and
ILIb production
EPA (PGE3). Dietary n-3 fatty acids can increase cellular n-3
content and decrease n-6 eicosanoid synthesis.
Dietary n-3 fats also suppress production of the peptide cytokines
interleukin ibeta (ILIB) and tumor necrosis factor alpha (TNFa).
These cytokines stimulate PGE2 synthesis and collagenase produc
tion, and increase expression of adhesion molecules that allow
leukocyte extravasation.293031
Epidemiologic studies suggest a role for N-3 supplementation in
RA. The consumption of baked or broiled fish appears to protect
against rheumatoid arthritis,33and the use of olive oil seems to have
the same effect.34
At least 13 prospective studies on the role of fish oils in the
symptomatic control of RA have been published in the English-
language literature. These are summarized in Table 2.
Table2.—Experimental studies of n-3 fatty acids in RA. Abbreviations used: EPA - eicosapentaenoic acid, DHA . docosahexaenoic acid, PUFA . polyunsaturated
fatty acids, gel - morning stiffness, NSAID . nonsteroidal antinflammatory drug, LT. leukotriene, IL- interleukin, TNF . tumor necrosis factor.
First Author, Year Subjects, Study Period Intervention Results
Kremer, 1985 (35) 37 1.8gm EPA; diet high in less pain and joint
12 weeks PUFA, low in saturated swelling, but rebound at
fats the end
Kremer, 1987 (36) 40 2.7 gm EPA less fatigue and joint
32 weeks 1.8 gm DHA swelling, decreased
LTB4
Magaro, 1988 (37) 12 1.6gm EPA less disease activity;
30 days 1.1 gm DHA less neutrophil
chemiluminescence
Van der Tempel, 1990 16 2.04 gm 20:5 n-3 less gel and joint
(38) 24 weeks 1.32gm 22:6 n-3 swelling, decreased
LTB4, increased LTBS
Tulleken, 1990 (39) 27 2.0 gm EPA less pain and fewer
12 weeks 1.3 gm DHA swollen joints
Kremer, 1990 (40) 49 27 mg/kg EPA more improvement with
24 weeks 18 mg/kg DHA, vs high dose fish oils;
54 mg.kg EPA decreased LTB4 and ILl;
36 mg/kg DHA vs olive oil also helped
6.8 gm oleic acid
(olive oil)
Nielsen, 1992 (41) 51 3.6gm n-3 PUFA less gel, less tenderness
12 weeks
Skoldstam, 1992 (42) 43 fish oil 10 gm/day decreased NSAID
6 months consumption
Espersen. 1992 (43) 32 3.6gm n-3 PUFA improved Ritchie’s index;
12 weeks drop in ILl; TNF and
complement
activation products
unchanged
Kjeldsen-Kragh, 1992 67 3.8 gm EPA fish oils mitigated impact
(44) 16 weeks 2.0 gm DHA with doses of naproxen withdrawal
of naproxen
Lau, 1993 (45) 64 10 MaxEPA caps/day decreased NSAID use
12 months
Geusens, 1994 (46) 90 2.6gm n-3 vs decreased medication use
12 months 6gm olive oil only in n-3-group
Kremer, 1995 (47) 66 4.6gm EPA, 2.5 gm diclofenac could be
30 weeks DHA stopped without a flare
diclofenac withdrawal
N-3 fatty acids suppress joint swelling and decrease pain in a dose-
dependent fashion. Inflammatory eicosanoid levels go down. The
more traditional laboratory measures of RA activity, such as the
sedimentation rate and complement degradation products, as well as
the titer of rheumatoid factor, are by and large untouched. The
clinical effect lasts no longer than four weeks after the supplements
are stopped. The magnitude of the response is not impressive—at
best, n-3 supplementation may have some drug-sparing properties,
allowing the patient to use lower doses of a antiinflammatory or
disease-modifier.
The plasma lipid alterations necessary to achieve clinically sig
nificant effects require 10 to 15 MaxEPA capsules a day. The same
levels can be achieved by including 4 to 6 meals with fish per week.
Some Practical Advice
What should the practitioner say to a patient who asks about the
relationship between non-gout inflammatory arthritis and his or her
diet? Data support these guidelines:
1. Inflammatory arthritis is a true food intolerance only in a very
small number of patients.
These people tend to have seronegative, nonerosive disease.
2. No foods or food groups have been consistently identified as a
cause, trigger or aggravating factor in unselected patients. How
ever, if one clearly experiences disease worsening with a particular
dietary item, then that item ought to be avoided. Some items that
have produced such worsening in a few individuals are dairy
products, nitrates, alcohol, simple sugars and azo dyes. Since the
ability of these foods and additives to cause disease flares is far from
universal, testing one’s reaction to each in turn makes better sense
than avoiding everything indiscriminately.
3. Fasting clearly suppresses inflammation in the joints. Fasting
should not be undertaken without medical supervision for longer
than five days. Fasting may be dangerous in the setting of previous
or ongoing medication intake, and should be discussed with the
medical practitioner. The benefits of fasting are very difficult to
sustain, but in some situations can be made to last by switching to a
vegan diet. The people who tend to respond favorably to such dietary
manipulation tend to be those who have had their disease for a
shorter period of time. End-stage, burnt-out disease with severejoint
destruction is unlikely to be helped by these measures.
4. Based on the work of Dr. Panush and this current report,
reasonable diets to try are the Dong diet and the HawaiifWaianae
diet. Books on both remain widely available in popular bookstores.
The responses reported are evident by 10 weeks; there is no data to
support staying on these diets longer than that period in the hope of
getting a delayed response. It must also be borne in mind that the
evidence that these diets work is limited and anecdotal.
5. Omega 3 fatty acids (fish oils) can help suppress joint inflamma
tion. The desired blood levels of the necessary fatty acids can be
obtained by eating six fatty fish meal a week. Fish oils are about as
effective as an NSAID. They do not reverse the basic immunologic
processses underlying RA.
6. The use of olive oil may be of some benefit.°
7. While diet can be a useful adjunct in the treatment of the
inflammatory arthropathies, there is no reliable and consistent way
to use it as monotherapy. It should be part of an integrated approach
that pays attention to proper rest and exercise, work modification,
family support, stress management and judiciously selected phar
macotherapy.
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Let our 6th grade
girls show your 5th grade
girls what learning can be
Take a peek at the animated
learning environment with
make-n-take art, science and
technology projects. Super Sixth
Grade Sunday for prospective
applicants, January 24th,
3:30 to 530.
2933 Poni Moi Road — Phone 922-2744
(at the base of Diamond Head)
